Fromkin Andrew J. (CIK 1341896) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-29). Recent activity: Buy IMVT (31,668 shares), Buy IMVT (71,492 shares), Buy IMVT (77,181 shares), Buy IMVT (16,260 shares), Sell IMVT (11,483 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Buy | 31,668 | $158,023 |
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Buy | 71,492 | $567,646 |
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Buy | 77,181 | $650,636 |
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Buy | 16,260 | $239,022 |
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Sell | 11,483 | $374,805 |
| 2026-05-29 | Immunovant, Inc. (IMVT) | Director | Sell | 210,468 | $7.1M |
| 2026-04-09 | Immunovant, Inc. (IMVT) | Director | Buy | 13,880 | $0 |
| 2025-12-03 | Immunovant, Inc. (IMVT) | Director | Sell | 19,351 | $447,782 |
| 2025-12-03 | Immunovant, Inc. (IMVT) | Director | Sell | 2,898 | $69,407 |
| 2025-04-03 | Immunovant, Inc. (IMVT) | Director | Buy | 16,188 | $0 |
| 2025-03-11 | Immunovant, Inc. (IMVT) | Director | Sell | 6,616 | $129,144 |
| 2025-03-11 | Immunovant, Inc. (IMVT) | Director | Sell | 1,384 | $27,625 |
Source: SEC Form 4 filings · as of 2026-05-29